Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging strategies in depression.

P M Grasby1

  • 1Hammersmith Hospital and Academic Department of Psychiatry, Imperial College School of Medicine, London, UK. grasby@wren.rpms.ac.uk

Journal of Psychopharmacology (Oxford, England)
|February 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.

NeuroImage·2010
Same author

Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis.

Molecular psychiatry·2009
Same author

Evidence for endogenous opioid release in the amygdala during positive emotion.

NeuroImage·2008
Same author

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.

Brain : a journal of neurology·2005
Same author

Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635.

Molecular psychiatry·2004
Same author

Imaging the neurochemical brain in health and disease.

Clinical medicine (London, England)·2002
Same journal

Effects of antidepressants, anesthetics and sedatives/hypnotics on sleep-associated memory consolidation - A systematic review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mental resilience is not meaningfully associated with the frequency and severity of alcohol hangover.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Psilocybin reduces fear memory and restores neuroplasticity in the hippocampus and medial prefrontal cortex.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.

Journal of psychopharmacology (Oxford, England)·2026
Same journal

Mitochondrial dysfunction in schizophrenia and its modulation by atypical antipsychotic drugs: A randomized controlled trial.

Journal of psychopharmacology (Oxford, England)·2026
See all related articles

Functional brain imaging reveals reduced activity in prefrontal areas of the brain in individuals with depression. Future research will focus on neurochemical imaging to understand depression

Area of Science:

  • Neuroscience
  • Psychiatry
  • Medical Imaging

Background:

  • Depressive disorder is associated with altered brain function, particularly in prefrontal regions.
  • Understanding the neuroanatomical and neurochemical basis of these functional deficits is crucial.

Purpose of the Study:

  • To map brain areas involved in depressive illness using functional brain imaging.
  • To identify neurochemical correlates of depression and its treatment response.

Main Methods:

  • Utilizing functional brain imaging techniques to assess neural activity.
  • Developing novel radiotracers for in vivo imaging of neurochemical systems, including serotonin and dopamine receptors.

Main Results:

  • Consistent detection of regional deficits in functional (neural) activity in subjects with ongoing affective symptoms.

Related Experiment Videos

  • Prefrontal areas are particularly implicated in these functional deficits.

    • Conclusions:

    • Functional brain imaging is a valuable tool for investigating the pathophysiology of depressive illness.
    • Further development of in vivo neurochemical imaging is necessary to fully elucidate the mechanisms of depression and treatment outcomes.